Skip to content

Free cash flow at other companies

Eli Lilly logo
Eli LillyLLY
$3.01B+1,828%
AbbVie logo
AbbVieABBV
$3.56B+155%
Establishment Labs logo
Establishment LabsESTA
-$6.16M+71.3%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$121M+26.0%

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s free cash flow?
AirSculpt Technologies, Inc. (AIRS) reported free cash flow of $5.22M in Q1 2026.
How has AirSculpt Technologies, Inc.'s free cash flow changed year-over-year?
AirSculpt Technologies, Inc.'s free cash flow increased by 605.3% year-over-year, from -$1.03M to $5.22M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.